-
June 2014 Benicar FDA Drug Safety Communication: Did It Decrease Or Increase Public Concern About The Risk Of Cardiovascular Death
Benicar, Azor, Tribenzor, Benicar HCT, And Other Blood Pressure Medicines Containing Olmesartan: Cardiovascular Mortality In Not A Side Effect Risk, Or Is It (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: "FDA Once Again Reaches Conclusions At…
-
Higher Doses Of Statin Drugs Such As Lipitor Associated With Higher Risk Of New-Onset Diabetes Mellitus (DM), Or Type-2 Diabetes
Recent Canadian Study Published In BMJ Medical Journal Suggests The Increased Risk Of Diabetes Seems To Be Highest In The First Four Months Of Statin Use (Posted by Tom Lamb at DrugInjuryWatch.com)According to the Parke-Davis,…
-
About 2000 YAZ / Yasmin / Ocella / Gianvi Blood Clot Cases Are Still Not Settled More Than Two Years After Bayer Began Settlement Mediations
Bayer Reports That As Of April 8, 2014 Settlement Negotiations Have Resolved "approximately 8,560 claimants in the U.S. for a total amount of about US$1.74 billion" (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE:…
-
European Drug Safety Regulators Reviewing Hydroxyzine-Containing Medicines Such As Atarax And Vistaril For Heart Side Effects
Adverse Events Monitoring Data And Medical Studies Have Identified Possible Increased Risk For Cardiovascular Problems Including Arrhythmias (Posted by Tom Lamb at DrugInjuryWatch.com)In early May 2014 the European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment…
